跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Omezar - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Omezar
Approved
STANDARD
Omezar
Alwin DMD Pharmaceuticals
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
c25142de5fa4cfe7
Company
Alwin DMD Pharmaceuticals
Type
Standard
Approval Details
Approval Id
c25142de5fa4cfe7
Drug Approval Philippines Name
Omezar
Product Name
Omezar
Registration Number
DRP-6717-17
Brand Name
Omezar
Generic Name
Omeprazole (as sodium)
Dosage Form
Lyophilized Powder for IV Injection
Dosage Strength
40mg
Manufacturer
Alwin DMD Pharmaceuticals
Importer
Bliss Pharma Distribution and Consultancy Corp
Distributor
Sanzar Pharmaceuticals Inc.
Issuance Date
26 May 2022
Expiry Date
02 June 2026
Pharmacologic Category
Proton Pump Inhibitor
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
c25142de5fa4cfe7
Type
Standard
Back to Philippines FDA Approvals